The South Korean Contract Research Organization Market

Government Initiatives Offer Powerful Boost to the Clinical Trials Industry

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This study presents an overview and analysis of the South Korean contract research organization (CRO) market. It provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and emerging trends. The study covers the complete life cycle of the CRO market, from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management. The research service also analyses market engineering measurements and research and development trends. The study period is 2014 (base year) to 2019.

Table of Contents

The South Korean Contract Research Organization MarketExecutive SummaryKey FindingsKey Findings (continued)Total CRO Market Size by Stages of Clinical DevelopmentMarket Size Estimation MethodologyScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)Pharmaceutical Market OverviewPharmaceutical Market OverviewPharmaceutical Market Overview (continued)Market PerspectiveClinical Trials—Market OverviewClinical Trials Market OverviewClinical Trials Market Overview (continued)Clinical Trials ScenarioProfiles of Clinical TrialsTotal CRO Market Segmentation by Stages of Clinical DevelopmentForecast and Trends—Total CRO MarketForecast AssumptionsMarket Engineering MeasurementsTotal CRO Market—Revenue ForecastTotal CRO Market—Revenue Forecast DiscussionTotal CRO Market—Phase I and Phase IITotal CRO Market—Phase III and Phase IVTotal CRO Market—Revenue Forecast for Preclinical TrialsRevenue Forecast Discussion for Preclinical Trials Total CRO Market—Revenue Forecast for Data ManagementRevenue Forecast Discussion for Data Management Total CRO Market—Revenue Forecast for BiostatisticsRevenue Forecast Discussion for BiostatisticsTotal CRO Market—Revenue Forecast for Central Laboratory ServicesRevenue Forecast Discussion for Central Laboratory Services Total CRO Market—Revenue Forecast for PharmacovigilanceRevenue Forecast Discussion for Pharmacovigilance Total CRO Market—Revenue Forecast for BioanalyticsRevenue Forecast Discussion for BioanalyticsTotal CRO Market—Revenue Forecast for HEORRevenue Forecast Discussion for HEORTotal CRO Market—Key TrendsRegulatory EnvironmentClinical Research Regulatory OverviewClinical Research Regulatory Overview (continued)Clinical Research Regulatory ProcessCompetitive EnvironmentCompetitive StructureCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)The Last WordThe Last WordLegal Disclaimer AppendixList of ExhibitsList of Exhibits (continued)List of Exhibits(continued)The Frost & Sullivan StoryThe Frost & Sullivan StoryValue PropositionGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 12-Oct-17

Region : Europe

Release Date : 28-Sep-17

Region : Europe

Release Date : 26-Sep-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.